© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
August 22, 2018
A potential first-in-class, oral medication to treat uterine fibroids has been accepted by the FDA.
July 13, 2018
The resubmitted biologics license application includes data from pivotal phase 3 studies of more than 11,000 patients.
July 12, 2018
Preliminary results from part 2 of the trial in patients with are expected in the second half of 2019.
July 11, 2018
The HVAD system is the only approved LVAD approved for implant via thoracotomy or median sternotomy.